161 related articles for article (PubMed ID: 16988256)
1. Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3.
Dennis VA; Jefferson A; Singh SR; Ganapamo F; Philipp MT
Infect Immun; 2006 Oct; 74(10):5780-9. PubMed ID: 16988256
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins.
Murthy PK; Dennis VA; Lasater BL; Philipp MT
Infect Immun; 2000 Dec; 68(12):6663-9. PubMed ID: 11083779
[TBL] [Abstract][Full Text] [Related]
3. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.
Giambartolomei GH; Dennis VA; Lasater BL; Philipp MT
Infect Immun; 1999 Jan; 67(1):140-7. PubMed ID: 9864208
[TBL] [Abstract][Full Text] [Related]
4. Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by
Duncan SA; Sahu R; Dixit S; Singh SR; Dennis VA
Mediators Inflamm; 2020; 2020():7461742. PubMed ID: 32684836
[TBL] [Abstract][Full Text] [Related]
5. Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys.
Giambartolomei GH; Dennis VA; Philipp MT
Infect Immun; 1998 Jun; 66(6):2691-7. PubMed ID: 9596735
[TBL] [Abstract][Full Text] [Related]
6. Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins.
Giambartolomei GH; Dennis VA; Lasater BL; Murthy PK; Philipp MT
Infect Immun; 2002 Apr; 70(4):1881-8. PubMed ID: 11895951
[TBL] [Abstract][Full Text] [Related]
7. Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice.
Gautam A; Dixit S; Embers M; Gautam R; Philipp MT; Singh SR; Morici L; Dennis VA
PLoS One; 2012; 7(9):e43860. PubMed ID: 23024745
[TBL] [Abstract][Full Text] [Related]
8. The early induction of suppressor of cytokine signaling 1 and the downregulation of toll-like receptors 7 and 9 induce tolerance in costimulated macrophages.
Lee HJ; Kim KC; Han JA; Choi SS; Jung YJ
Mol Cells; 2015 Jan; 38(1):26-32. PubMed ID: 25518931
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of suppressors of cytokine signaling during infection with Mycobacterium tuberculosis in human THP-1-derived macrophages and in mice.
Roy T; Seth A; Shafi H; Reddy DVS; Raman SK; Chakradhar JVUS; Verma S; Bharti R; Azmi L; Ray L; Misra A
Microbes Infect; 2024; 26(3):105282. PubMed ID: 38135025
[TBL] [Abstract][Full Text] [Related]
10. A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and function in vitro and in vivo.
Arnold CE; Whyte CS; Gordon P; Barker RN; Rees AJ; Wilson HM
Immunology; 2014 Jan; 141(1):96-110. PubMed ID: 24088176
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis.
Ramesh G; Borda JT; Dufour J; Kaushal D; Ramamoorthy R; Lackner AA; Philipp MT
Am J Pathol; 2008 Nov; 173(5):1415-27. PubMed ID: 18832582
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of SOCS impairs the anti-leishmanial immune response.
Jafarzadeh A; Gurjar D; Bodhale N; Jafarzadeh S; Nemati M; Sharifi I; Saha B
Cytokine; 2024 Feb; 174():156461. PubMed ID: 38065046
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production.
Scheller EL; Hankenson KD; Reuben JS; Krebsbach PH
J Cell Biochem; 2011 Nov; 112(11):3364-72. PubMed ID: 21751240
[TBL] [Abstract][Full Text] [Related]
14. Macrophage mediated recognition and clearance of Borrelia burgdorferi elicits MyD88-dependent and -independent phagosomal signals that contribute to phagocytosis and inflammation.
Benjamin SJ; Hawley KL; Vera-Licona P; La Vake CJ; Cervantes JL; Ruan Y; Radolf JD; Salazar JC
BMC Immunol; 2021 May; 22(1):32. PubMed ID: 34000990
[TBL] [Abstract][Full Text] [Related]
15. Suppression of SOCS3 expression in macrophage cells: Potential application in diabetic wound healing.
Amoupour M; Brouki Milan P; Barati M; Hivechi A; Rajabi Fomeshi M; Kiani Ghalesardi O; Ahmadvand D; Karkuki Osguei N; Samadikuchaksaraei A
Int J Biol Macromol; 2024 Mar; 262(Pt 1):129876. PubMed ID: 38310055
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease.
Oosting M; ter Hofstede H; van de Veerdonk FL; Sturm P; Kullberg BJ; van der Meer JW; Netea MG; Joosten LA
Infect Immun; 2011 Nov; 79(11):4681-7. PubMed ID: 21896776
[TBL] [Abstract][Full Text] [Related]
17. The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi.
Bernardino AL; Kaushal D; Philipp MT
J Infect Dis; 2009 May; 199(9):1379-88. PubMed ID: 19301981
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive genetic map of cytokine responses in Lyme borreliosis.
Botey-Bataller J; Vrijmoeth HD; Ursinus J; Kullberg BJ; van den Wijngaard CC; Ter Hofstede H; Alaswad A; Gupta MK; Roesner LM; Huehn J; Werfel T; Schulz TF; Xu CJ; Netea MG; Hovius JW; Joosten LAB; Li Y
Nat Commun; 2024 May; 15(1):3795. PubMed ID: 38714679
[TBL] [Abstract][Full Text] [Related]
19. Primary Human Microglia Are Phagocytically Active and Respond to
Greenmyer JR; Gaultney RA; Brissette CA; Watt JA
Front Microbiol; 2018; 9():811. PubMed ID: 29922241
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptor inhibitors mitigate the neuropathogenicity of
Parthasarathy G
Front Immunol; 2024; 15():1327416. PubMed ID: 38638441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
